Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults

Written By Yiran Gan

2023.10.12

Y.-J. Lee, S.-Y. Lin, S.-W. Peng, Y.-C. Lin, T.-B. Chen, P.-N. Wang and I. H. Cheng 

 J Prev Alzheimers Dis 10, 178–185 (2023).

https://pubmed.ncbi.nlm.nih.gov/36946444/


Yiran Gan
Previous

Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model
Next

Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study